Treatment of T1b glottic SCC: Laser vs. radiation- a Canadian multicenter study
Authors:
- S Mark TaylorSTS Mark Taylor
- Paul KerrPKPaul Kerr
- Kevin FungKFKevin Fung
- Mankavil K AneeshkumarMAMankavil K Aneeshkumar
- Derek WilkeDWDerek Wilke
- Yida JiangYJYida Jiang
- John ScottJSJohn Scott
- Judith PhillipsJPJudith Phillips
- Robert D HartRHRobert D Hart
- Jonathan Rb TritesJTJonathan Rb Trites
- Matthew H RigbyMRMatthew H Rigby
Open Access
- 1 January 2013
- journal article
- research article
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 42 (1) , 22
Abstract
Objective: To assess the oncological and functional outcomes of T1b squamous cell carcinoma (SCC) of the glottic larynx treated with laser in comparison with radiation. Design: A Canadian multicenter cohort study. Setting: Three tertiary referral centers for head and neck cancer- Dalhousie University in Halifax, Nova Scotia, Western University in London, Ontario and the University of Manitoba, Winnipeg. Methods: Patients with T1b glottic SCC who underwent transoral laser resection or radiation as the primary modality of treatment. Outcome measures: Oncological outcomes were evaluated using local control, laryngeal preservation, disease free survival and disease specific survival. Voice outcomes were assessed using the Voice Handicap Index-10 (VHI-10). Results: 63 patients met study criteria. 21 were treated with laser and 42 with radiation. Oncologic outcomes at 2 years for laser and radiation demonstrated local control of 95% and 85.9%; laryngeal preservation of 100% and 85.9%; disease free survival of 88.7% and 85.9% and overall survival of 94.1% and 94.8% respectively. VHI-10 data was available for 23/63 patients. During the last follow up visit VHI-10 ranged from 0 to 11 (median 6) in the laser group and 0 to 34 (median 7) in the radiation group. Conclusion: T1b SCC of the glottis can be effectively treated with transoral laser microsurgery with oncological outcomes that are at least equivalent to radiation. For patients with VHI scores, voice quality was similar between the two groups. To our knowledge this is the first study directly comparing the oncologic and voice outcomes with laser and radiation for the treatment of glottic cancer involving the anterior commissure.Keywords
This publication has 25 references indexed in Scilit:
- Consensus statement on management in the UK: Transoral laser assisted microsurgical resection of early glottic cancerClinical Otolaryngology, 2009
- Endoscopic laser surgery of early glottic cancer: Involvement of the anterior commissureHead & Neck, 2009
- Clinical outcome of T1 glottic carcinoma since the introduction of endoscopic CO2 laser surgery as treatment optionHead & Neck, 2008
- Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 diseaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Letter to the editorHead & Neck, 2005
- Impact of Anterior Commissure Involvement on Local Control of Early Glottic Carcinoma Treated by Laser MicroresectionThe Laryngoscope, 2004
- CO2 Laser Cordectomy for Early‐Stage Glottic Carcinoma: A Long‐Term Follow‐up of 156 CasesThe Laryngoscope, 2002
- Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Factors Associated With Recurrence and Voice Quality Following Radiation Therapy for T1 and T2 Glottic CarcinomasThe Laryngoscope, 1994
- Morphological Study of the Laryngeal Anterior Commissure with Regard to the Spread of CancerActa Oto-Laryngologica, 1981